I was told I'm being overly optimistic. Part of t
Post# of 72440
But I'll go on. I consider my dd over the last 6 - 7 years on CTIX/IPIX just as important as the studies themselves by the company. Otherwise I would have moved on long ago.
All trials successful to date.
Lets run prurisol, my scores...
How bout a WHO of much greater than 75%. Possibly 85 - 90%. And we could still be impressed even more. Or not. But I think it moves on favorably.
Brilacidin topical treatments. The brilacidin franchise. What we know is looking pretty solid to move on. brilacidin ABBBSI may be coming back to life in due time. B-OM is the worm on the hook.
Kevetrin oral. Temporarily paused but about half way through toxicology.
The prudence of controlling dilution to move forward under a partnership is just that. Time to see if Leo and Dr. B made the right choices is drawing close.
Now where did I put my crystal ball?